Skip to main navigation Skip to search Skip to main content

APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy

  • Audrey DunnGalvin
  • , Katharina Blumchen
  • , Frans Timmermans
  • , Lynne Regent
  • , Sabine Schnadt
  • , Marcia Podestà
  • , Angel Sánchez
  • , Pascale Couratier
  • , Mary Feeney
  • , Betina Hjorth
  • , Ram Patel
  • , Tessa Lush
  • , Robert Ryan
  • , Andrea Vereda
  • , Montserrat Fernández-Rivas
  • , Helen R. Fisher
  • Pirogov Russian National Research Medical University
  • Goethe University Frankfurt
  • Nederlands Anafylaxis Netwerk—European Anaphylaxis Taskforce
  • Anaphylaxis UK
  • Deutscher Allergie- und Asthmabund (DAAB)
  • Food Allergy Italia
  • Asociación Española de Personas con Alergia a Alimentos y Látex
  • Association Française de Prévention des Allergies (AFPRAL)
  • Guy's and St Thomas' NHS Foundation Trust
  • Astma-Allergi Danmark
  • Brainsell Ltd.
  • Aimmune Therapeutics
  • Complutense University

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Peanut allergy (PA) is a common, potentially life-threatening and typically lifelong condition with a significant burden of illness. However, information is lacking on how persons with PA (PwPA) and their caregivers perceive the psychosocial impact of living with PA. The Allergy to Peanuts imPacting Emotions And Life 1 (APPEAL-1) survey, conducted across Europe, investigated the experience and impact of living with PA. Here, we report data evaluating the psychosocial impact of PA on PwPA and their caregivers. Methods: Allergy to Peanuts imPacting Emotions And Life study 1 was an online survey conducted in eight European countries. Representatives of eight patient advocacy groups and five healthcare-research specialists developed the survey. Eligible respondent groups included the following: adults diagnosed with PA (self-report); parent/nonparent caregivers (proxy-report for a child with PA); and parent/nonparent caregivers (self-report of PA impact on themselves). Results: Of 1846 total study respondents, 419 were adults with PA (self-report); 546 were parents/caregivers (proxy-report); and 881 were parents/caregivers (self-report). Most respondents reported lifestyle restrictions regarding food (84%-93%) and additional domains including parties and socializing, holiday activities and destinations, and taking public transport (53%-89%). Approximately 40% rated themselves as “very” frustrated and “very” stressed. Two-thirds (65%) felt socially isolated; 43% were bullied. Less than half felt confident in knowing when to use an adrenaline autoinjector. Several intercountry differences were observed such as high levels of uncertainty and stress in respondents from Ireland, highest rates of anxiety in respondents from Germany, and social exclusion and isolation most common in respondents from France. Conclusions: Peanut allergy imposes an adverse psychosocial impact on patients and caregivers, leading to frustration, stress and isolation. Attention to the impact of PA is needed in research and clinical practice to improve PA healthcare and public education programmes.

Original languageEnglish
Pages (from-to)2899-2908
Number of pages10
JournalAllergy: European Journal of Allergy and Clinical Immunology
Volume75
Issue number11
DOIs
Publication statusPublished - 1 Nov 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 11 - Sustainable Cities and Communities
    SDG 11 Sustainable Cities and Communities

Keywords

  • bullying
  • coping
  • daily life
  • peanut allergy
  • psychosocial impacts

Fingerprint

Dive into the research topics of 'APPEAL-1: A multiple-country European survey assessing the psychosocial impact of peanut allergy'. Together they form a unique fingerprint.

Cite this